Amount Raised
$35 Million
Round Type
Series A
DurhamBiotechnologyHealthcareHealth CareInvestors
Description
Tellus Therapeutics, a neonatal care company developing treatments for newborns in the neonatal intensive care unit (NICU), announced today the closing of a Series A financing round of $35 million led by the Perceptive Xontogeny Venture Fund (“PXV Fund”). The capital will be used to continue important preclinical work conducted through the seed investment with the Xontogeny development team and to advance TT-20, the company’s lead candidate for the treatment of white matter brain injury in preterm infants, as well as the company’s pipeline programs.
Quick answer
Tellus Therapeutics raised $35 Million in a Series A round, dated December 13, 2022. Investors: Perceptive Xontogeny Venture Fund. Tellus Therapeutics is based in Durham, North Carolina, United States.
- How much did Tellus Therapeutics raise?
- Tellus Therapeutics raised $35 Million in a Series A round on December 13, 2022.
- Who invested in Tellus Therapeutics?
- Perceptive Xontogeny Venture Fund is named as investors in this round.
- What does Tellus Therapeutics do?
- Tellus Therapeutics is a neonatal care company developing safe and effective interventions for unmet needs of newborns.
- Where is Tellus Therapeutics based and how big is it?
- Tellus Therapeutics is based in Durham, North Carolina, United States.
Source: Fundz verified event record.
Who else raised in Healthcare and Biotechnology around the same time
Companies in the same sectors as Tellus Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Inhibikase Therapeutics raised $4.2M (Seed) on January 27, 2023.
- ADARx Pharmaceuticals, Inc. raised $46M on January 26, 2023.
- Streamex Corp. raised $234K (Seed) on January 25, 2023.
- Streamex Corp. raised $1.9M (Seed) on January 23, 2023.
- Otolith Labs raised $25M on January 23, 2023.
- ADARx Pharmaceuticals, Inc. raised $46M (Funding Round) on January 20, 2023.
Who to call at Tellus Therapeutics, and when
A new round usually means Tellus Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Tellus Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Tellus Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Tellus Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Tellus Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Funding Insights
What this usually meansTellus Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.